{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T20:00:36Z","timestamp":1775851236901,"version":"3.50.1"},"reference-count":71,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["cancerletters.info","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1016\/j.canlet.2014.02.024","type":"journal-article","created":{"date-parts":[[2014,3,16]],"date-time":"2014-03-16T17:46:04Z","timestamp":1394991964000},"page":"224-230","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"special_numbering":"PA","title":["How folate metabolism affects colorectal cancer development and treatment; a story of heterogeneity and pleiotropy"],"prefix":"10.1016","volume":"356","author":[{"given":"Barbara Anne","family":"Jennings","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gavin","family":"Willis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2014.02.024_b0005","unstructured":"Pharmacogenetic testing to predict serious toxicity from 5-fluorouracil (5-FU) for patients administered 5-FU-based chemotherapy for cancer, Technology Evaluation Center Assessment Program. Executive summary, 24 (2010) 1\u20133."},{"key":"10.1016\/j.canlet.2014.02.024_b0010","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.2217\/pgs.11.83","article-title":"The association of polymorphisms in 5-fluorouracil metabolism genes with outcome in adjuvant treatment of colorectal cancer","volume":"12","author":"Afzal","year":"2011","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.canlet.2014.02.024_b0015","doi-asserted-by":"crossref","first-page":"3822","DOI":"10.1158\/1078-0432.CCR-11-0304","article-title":"Combinations of polymorphisms in genes involved in the 5-fluorouracil metabolism pathway are associated with gastrointestinal toxicity in chemotherapy-treated colorectal cancer patients","volume":"17","author":"Afzal","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2014.02.024_b0020","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1126\/science.102.2644.227","article-title":"Synthesis of a compound identical with the L. Casei factor isolated from liver","volume":"102","author":"Angier","year":"1945","journal-title":"Science"},{"key":"10.1016\/j.canlet.2014.02.024_b0025","doi-asserted-by":"crossref","first-page":"5519","DOI":"10.1200\/JCO.2008.21.6283","article-title":"Association of molecular markers with toxicity outcomes in a randomized trial of chemotherapy for advanced colorectal cancer: the FOCUS trial","volume":"27","author":"Braun","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.canlet.2014.02.024_b0030","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1093\/annonc\/mdf089","article-title":"Colorectal cancer study, First-line oral capecitabine therapy in metastatic colorectal cancer: a favorable safety profile compared with intravenous 5-fluorouracil\/leucovorin","volume":"13","author":"Cassidy","year":"2002","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.canlet.2014.02.024_b0035","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1017\/S1368980012003576","article-title":"Impact of folic acid fortification of flour on neural tube defects: a systematic review","volume":"16","author":"Castillo-Lancellotti","year":"2013","journal-title":"Public Health Nutr."},{"key":"10.1016\/j.canlet.2014.02.024_b0040","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1038\/clpt.2013.172","article-title":"Clinical pharmacogenetics implementation consortium guidelines for dihydropyrimidine dehydrogenase genotype and fluoropyrimidine dosing","volume":"94","author":"Caudle","year":"2013","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.canlet.2014.02.024_b0045","first-page":"1611","article-title":"Methylenetetrahydrofolate reductase polymorphism in advanced colorectal cancer: a novel genomic predictor of clinical response to fluoropyrimidine-based chemotherapy","volume":"9","author":"Cohen","year":"2003","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2014.02.024_b0050","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1001\/jama.297.21.2351","article-title":"G. polyp prevention study, folic acid for the prevention of colorectal adenomas: a randomized clinical trial","volume":"297","author":"Cole","year":"2007","journal-title":"JAMA: J. Am. Med. Assoc."},{"key":"10.1016\/j.canlet.2014.02.024_b0055","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1158\/0008-5472.CAN-08-2023","article-title":"Chemoresistant colorectal cancer cells, the cancer stem cell phenotype, and increased sensitivity to insulin-like growth factor-I receptor inhibition","volume":"69","author":"Dallas","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2014.02.024_b0060","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1001\/jama.1995.03530210052030","article-title":"Folate levels and neural tube defects. Implications for prevention","volume":"274","author":"Daly","year":"1995","journal-title":"JAMA: J. Am. Med. Assoc."},{"key":"10.1016\/j.canlet.2014.02.024_b0065","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/tpj.2010.43","article-title":"Association of thymidylate synthase enhancer region polymorphisms with thymidylate synthase activity in vivo","volume":"11","author":"de Bock","year":"2011","journal-title":"Pharmacogenomics J."},{"key":"10.1016\/j.canlet.2014.02.024_b0070","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1038\/nsmb.2089","article-title":"DNA secondary structures and epigenetic determinants of cancer genome evolution","volume":"18","author":"De","year":"2011","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.canlet.2014.02.024_b0075","doi-asserted-by":"crossref","first-page":"e60508","DOI":"10.1371\/journal.pone.0060508","article-title":"Methionine synthase A2756G polymorphism and risk of colorectal adenoma and cancer: evidence based on 27 studies","volume":"8","author":"Ding","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.canlet.2014.02.024_b0080","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1002\/path.4139","article-title":"Use of multivariate analysis to suggest a new molecular classification of colorectal cancer","volume":"229","author":"Domingo","year":"2013","journal-title":"J. Pathol."},{"key":"10.1016\/j.canlet.2014.02.024_b0085","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s10545-010-9128-0","article-title":"Folate and cancer: how DNA damage, repair and methylation impact on colon carcinogenesis","volume":"34","author":"Duthie","year":"2011","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.canlet.2014.02.024_b0090","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1001\/jama.2009.1622","article-title":"Cancer incidence and mortality after treatment with folic acid and vitamin B12","volume":"302","author":"Ebbing","year":"2009","journal-title":"JAMA: J. Am. Med. Assoc."},{"key":"10.1016\/j.canlet.2014.02.024_b0095","unstructured":"N.I.f.H.a.C. Excellence, (Anaemia-B12 and folate deficiency), National Institute for Health and Care Excellence, London, 2013."},{"key":"10.1016\/j.canlet.2014.02.024_b0100","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/tpj.2012.2","article-title":"Pharmacogenomics in colorectal cancer: a genome-wide association study to predict toxicity after 5-fluorouracil or FOLFOX administration","volume":"13","author":"Fernandez-Rozadilla","year":"2013","journal-title":"Pharmacogenomics J."},{"key":"10.1016\/j.canlet.2014.02.024_b0105","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/sj.ejcn.1602315","article-title":"Research goals for folate and related B vitamin in Europe","volume":"60","author":"Finglas","year":"2006","journal-title":"Eur. J. Clin. Nutr."},{"key":"10.1016\/j.canlet.2014.02.024_b0110","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/ng0595-111","article-title":"A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase","volume":"10","author":"Frosst","year":"1995","journal-title":"Nat. Genet."},{"key":"10.1016\/j.canlet.2014.02.024_b0115","doi-asserted-by":"crossref","first-page":"e34426","DOI":"10.1371\/journal.pone.0034426","article-title":"Analysis of polymorphisms and haplotype structure of the human thymidylate synthase genetic region: a tool for pharmacogenetic studies","volume":"7","author":"Ghosh","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.canlet.2014.02.024_b0120","doi-asserted-by":"crossref","first-page":"750","DOI":"10.4161\/cbt.12.8.16867","article-title":"Reexamining a proposal: thymidylate synthase 5\u2019-untranslated region as a regulator of translation efficiency","volume":"12","author":"Ghosh","year":"2011","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.canlet.2014.02.024_b0125","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1038\/sj.bjc.6605052","article-title":"Predictors of survival and toxicity in patients on adjuvant therapy with 5-fluorouracil for colorectal cancer","volume":"100","author":"Gusella","year":"2009","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.canlet.2014.02.024_b0130","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1172\/JCI104589","article-title":"Interrelations of vitamin B12 and folic acid metabolism: folic acid clearance studies","volume":"41","author":"Herbert","year":"1962","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.canlet.2014.02.024_b0135","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1097\/MEG.0b013e328306ccdb","article-title":"Colon cancer in Chile before and after the start of the flour fortification program with folic acid","volume":"21","author":"Hirsch","year":"2009","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.canlet.2014.02.024_b0140","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1247\/csf.20.191","article-title":"Functional analysis and DNA polymorphism of the tandemly repeated sequences in the 5\u2032-terminal regulatory region of the human gene for thymidylate synthase","volume":"20","author":"Horie","year":"1995","journal-title":"Cell Struct. Funct."},{"key":"10.1016\/j.canlet.2014.02.024_b0145","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1097\/FPC.0b013e328351875d","article-title":"Functional polymorphisms of folate metabolism and response to chemotherapy for colorectal cancer, a systematic review and meta-analysis","volume":"22","author":"Jennings","year":"2012","journal-title":"Pharmacogenet. Genomics"},{"key":"10.1016\/j.canlet.2014.02.024_b0150","doi-asserted-by":"crossref","first-page":"e78053","DOI":"10.1371\/journal.pone.0078053","article-title":"Evaluating predictive pharmacogenetic signatures of adverse events in colorectal cancer patients treated with fluoropyrimidines","volume":"8","author":"Jennings","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.canlet.2014.02.024_b0155","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1053\/j.gastro.2010.12.035","article-title":"5-Fluorouracil adjuvant chemotherapy does not increase survival in patients with CpG island methylator phenotype colorectal cancer","volume":"140","author":"Jover","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.canlet.2014.02.024_b0160","first-page":"6004","article-title":"Identification and functional analysis of single nucleotide polymorphism in the tandem repeat sequence of thymidylate synthase gene","volume":"63","author":"Kawakami","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2014.02.024_b0165","first-page":"4308","article-title":"Human chromosome 3 corrects mismatch repair deficiency and microsatellite instability and reduces N-methyl-N\u2032-nitro-N-nitrosoguanidine tolerance in colon tumor cells with homozygous hMLH1 mutation","volume":"54","author":"Koi","year":"1994","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2014.02.024_b0170","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1136\/bmj.282.6275.1509","article-title":"Double-blind randomised controlled trial of folate treatment before conception to prevent recurrence of neural-tube defects","volume":"282","author":"Laurence","year":"1981","journal-title":"Br. Med. J."},{"key":"10.1016\/j.canlet.2014.02.024_b0175","doi-asserted-by":"crossref","first-page":"5880","DOI":"10.1158\/1078-0432.CCR-04-0169","article-title":"Thymidylate synthase gene polymorphism predicts toxicity in colorectal cancer patients receiving 5-fluorouracil-based chemotherapy","volume":"10","author":"Lecomte","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2014.02.024_b0180","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1038\/bjc.2013.262","article-title":"Pharmacogenetic variants in the DPYD, TYMS, CDA and MTHFR genes are clinically significant predictors of fluoropyrimidine toxicity","volume":"108","author":"Loganayagam","year":"2013","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.canlet.2014.02.024_b0185","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nrc1074","article-title":"5-fluorouracil: mechanisms of action and clinical strategies","volume":"3","author":"Longley","year":"2003","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.canlet.2014.02.024_b0190","article-title":"Gene-environment interactions and the risk of childhood acute lymphoblastic leukemia: exploring the role of maternal folate genes and folic acid fortification","author":"Lupo","year":"2013","journal-title":"Pediatr. Hematol. Oncol."},{"key":"10.1016\/j.canlet.2014.02.024_b0195","first-page":"2898","article-title":"A novel single nucleotide polymorphism within the 5\u2032 tandem repeat polymorphism of the thymidylate synthase gene abolishes USF-1 binding and alters transcriptional activity","volume":"63","author":"Mandola","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2014.02.024_b0200","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/00008571-200405000-00007","article-title":"A 6 bp polymorphism in the thymidylate synthase gene causes message instability and is associated with decreased intratumoral TS mRNA levels","volume":"14","author":"Mandola","year":"2004","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.canlet.2014.02.024_b0205","doi-asserted-by":"crossref","first-page":"e1001453","DOI":"10.1371\/journal.pmed.1001453","article-title":"Gene expression classification of colon cancer into molecular subtypes: characterization, validation, and prognostic value","volume":"10","author":"Marisa","year":"2013","journal-title":"PLoS Med."},{"key":"10.1016\/j.canlet.2014.02.024_b0210","first-page":"383","article-title":"Polymorphism in the thymidylate synthase promoter enhancer region in colorectal cancer","volume":"19","author":"Marsh","year":"2001","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.canlet.2014.02.024_b0215","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1158\/1055-9965.EPI-07-0329","article-title":"A temporal association between folic acid fortification and an increase in colorectal cancer rates may be illuminating important biological principles: a hypothesis","volume":"16","author":"Mason","year":"2007","journal-title":"Cancer Epidemiology, Biomarkers & Prevention: A Publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology"},{"key":"10.1016\/j.canlet.2014.02.024_b0220","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1186\/1471-2407-11-344","article-title":"The CpG island methylator phenotype may confer a survival benefit in patients with stage II or III colorectal carcinomas receiving fluoropyrimidine-based adjuvant chemotherapy","volume":"11","author":"Min","year":"2011","journal-title":"BMC Cancer"},{"key":"10.1016\/j.canlet.2014.02.024_b0225","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1016\/S0140-6736(96)12049-3","article-title":"Thermolabile variant of 5,10-methylenetetrahydrofolate reductase associated with low red-cell folates: implications for folate intake recommendations","volume":"349","author":"Molloy","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.canlet.2014.02.024_b0230","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1200\/JCO.2004.05.064","article-title":"Thymidylate synthase expression and prognosis in colorectal cancer: a systematic review and meta-analysis","volume":"22","author":"Popat","year":"2004","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.canlet.2014.02.024_b0235","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1017\/S0007114507795326","article-title":"Folic acid under scrutiny","volume":"98","author":"Powers","year":"2007","journal-title":"Br. J. Nutr."},{"key":"10.1016\/j.canlet.2014.02.024_b0240","doi-asserted-by":"crossref","first-page":"23456","DOI":"10.1074\/jbc.M600282200","article-title":"Differential stability of thymidylate synthase 3\u2019-untranslated region polymorphic variants regulated by AUF1","volume":"281","author":"Pullmann","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2014.02.024_b0245","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/nm.3175","article-title":"A colorectal cancer classification system that associates cellular phenotype and responses to therapy","volume":"19","author":"Sadanandam","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.canlet.2014.02.024_b0250","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1002\/ijc.20648","article-title":"Folate intake and colorectal cancer risk: a meta-analytical approach","volume":"113","author":"Sanjoaquin","year":"2005","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.canlet.2014.02.024_b0255","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1365-2141.1977.tb00639.x","article-title":"Cobalamin dependent methionine synthesis and methyl-folate-trap in human vitamin B12 deficiency","volume":"36","author":"Sauer","year":"1977","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.canlet.2014.02.024_b0260","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1136\/bmj.306.6880.752","article-title":"Randomised comparison of combination chemotherapy plus supportive care with supportive care alone in patients with metastatic colorectal cancer","volume":"306","author":"Scheithauer","year":"1993","journal-title":"BMJ"},{"key":"10.1016\/j.canlet.2014.02.024_b0265","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1093\/aje\/kwh066","article-title":"Polymorphisms in genes involved in folate metabolism and colorectal neoplasia: a HuGE review","volume":"159","author":"Sharp","year":"2004","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.canlet.2014.02.024_b0270","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.jnutbio.2006.11.010","article-title":"Red blood cell folate vitamer distribution in healthy subjects is determined by the methylenetetrahydrofolate reductase C677T polymorphism and by the total folate status","volume":"18","author":"Smulders","year":"2007","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.canlet.2014.02.024_b0275","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.3945\/jn.109.113670","article-title":"One-carbon metabolism\u2013genome interactions in folate-associated pathologies","volume":"139","author":"Stover","year":"2009","journal-title":"J. Nutr."},{"key":"10.1016\/j.canlet.2014.02.024_b0280","first-page":"3057","article-title":"Gene polymorphisms MTHFRC677T and MTRA2756G as predictive factors in adjuvant chemotherapy for stage III colorectal cancer","volume":"31","author":"Taflin","year":"2011","journal-title":"Anticancer Res."},{"key":"10.1016\/j.canlet.2014.02.024_b0285","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1093\/aje\/kwp275","article-title":"Meta- and pooled analyses of the methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism and colorectal cancer: a HuGE-GSEC review","volume":"170","author":"Taioli","year":"2009","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.canlet.2014.02.024_b0290","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/FPC.0b013e328348c6f2","article-title":"PharmGKB summary: fluoropyrimidine pathways","volume":"21","author":"Thorn","year":"2011","journal-title":"Pharmacogenet. Genomics"},{"key":"10.1016\/j.canlet.2014.02.024_b0295","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S0959-8049(00)00444-5","article-title":"Colorectal cancer study, capecitabine (Xeloda) improves medical resource use compared with 5-fluorouracil plus leucovorin in a phase III trial conducted in patients with advanced colorectal carcinoma","volume":"37","author":"Twelves","year":"2001","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.canlet.2014.02.024_b0300","doi-asserted-by":"crossref","first-page":"4097","DOI":"10.1200\/JCO.2001.19.21.4097","article-title":"G. Xeloda colorectal cancer study, oral capecitabine compared with intravenous fluorouracil plus leucovorin in patients with metastatic colorectal cancer: results of a large phase III study","volume":"19","author":"Van Cutsem","year":"2001","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.canlet.2014.02.024_b0305","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1016\/S0959-8049(97)00261-X","article-title":"Heterozygosity for a point mutation in an invariant splice donor site of dihydropyrimidine dehydrogenase and severe 5-fluorouracil related toxicity","volume":"33","author":"Van Kuilenburg","year":"1997","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.canlet.2014.02.024_b0310","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.phrs.2011.04.006","article-title":"Thymidylate synthase expression and genotype have no major impact on the clinical outcome of colorectal cancer patients treated with 5-fluorouracil","volume":"64","author":"Vignoli","year":"2011","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.canlet.2014.02.024_b0315","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1136\/bmj.39000.486701.68","article-title":"Folic acid, homocysteine, and cardiovascular disease: judging causality in the face of inconclusive trial evidence","volume":"333","author":"Wald","year":"2006","journal-title":"Bmj"},{"key":"10.1016\/j.canlet.2014.02.024_b0320","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1158\/1940-6207.CAPR-10-0047","article-title":"Association between folate levels and CpG Island hypermethylation in normal colorectal mucosa","volume":"3","author":"Wallace","year":"2010","journal-title":"Cancer Prevent. Res."},{"key":"10.1016\/j.canlet.2014.02.024_b0325","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1042\/bj0312136","article-title":"A new factor in the production and cure of macrocytic anaemias and its relation to other haemopoietic principles curative in pernicious anaemia","volume":"31","author":"Wills","year":"1937","journal-title":"Biochem J."},{"key":"10.1016\/j.canlet.2014.02.024_b0330","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s00280-005-1018-z","article-title":"Polymorphic tandem repeat sequences of the thymidylate synthase gene correlates with cellular-based sensitivity to fluoropyrimidine antitumor agents","volume":"56","author":"Yawata","year":"2005","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.canlet.2014.02.024_b0335","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1038\/ejhg.2009.131","article-title":"Methionine synthase A2756G polymorphism and cancer risk: a meta-analysis","volume":"18","author":"Yu","year":"2010","journal-title":"Eur. J. Hum. Genet.: EJHG"},{"key":"10.1016\/j.canlet.2014.02.024_b0340","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1200\/JCO.1997.15.6.2432","article-title":"Adjuvant chemotherapy in colorectal cancer with high-dose leucovorin and fluorouracil: impact on disease-free survival and overall survival","volume":"15","author":"Zaniboni","year":"1997","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.canlet.2014.02.024_b0345","first-page":"831","article-title":"Capecitabine plus oxaliplatin compared with 5-fluorouracil plus oxaliplatin in metastatic colorectal cancer: meta-analysis of randomized controlled trials","volume":"3","author":"Zhang","year":"2012","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.canlet.2014.02.024_b0350","doi-asserted-by":"crossref","first-page":"819","DOI":"10.7150\/ijbs.4462","article-title":"The polymorphisms in methylenetetrahydrofolate reductase, methionine synthase, methionine synthase reductase, and the risk of colorectal cancer","volume":"8","author":"Zhou","year":"2012","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.canlet.2014.02.024_b0355","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.2217\/pgs.09.59","article-title":"MTHFR gene polymorphisms and response to chemotherapy in colorectal cancer: a meta-analysis","volume":"10","author":"Zintzaras","year":"2009","journal-title":"Pharmacogenomics"}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383514001311?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383514001311?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T09:55:47Z","timestamp":1565258147000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383514001311"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":71,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["S0304383514001311"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2014.02.024","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"How folate metabolism affects colorectal cancer development and treatment; a story of heterogeneity and pleiotropy","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2014.02.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}